Results
Baxter International Inc.
10/21/2025 | Press release | Distributed by Public on 10/21/2025 07:01
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 16, 2025, Heather Knight notified Baxter International Inc. (the "Company") of her decision to resign as the Company's Executive Vice President, Chief Operating Officer ("COO") and interim group president of Medical Products and Therapies ("MPT"), effective as of October 29, 2025 (the "Transition Date"), to join a company in the healthcare industry.
In connection with Ms. Knight's departure, Andrew Hider, the Company's President and Chief Executive Officer, will also assume the role of interim group president of MPT effective as of the Transition Date. Additionally, as of the Transition Date, the Company will no longer have a COO.
Baxter International Inc. published this content on October 21, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on October 21, 2025 at 13:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]